Richard Lanigan serves as the Vice President at Gynesonics, Inc., where he plays a pivotal role in shaping the clinical evidence strategy that underpins the company’s innovative approach to women's healthcare. With a strong focus on developing and commercializing advanced incision-free, uterine-preserving technologies for the...
Richard Lanigan serves as the Vice President at Gynesonics, Inc., where he plays a pivotal role in shaping the clinical evidence strategy that underpins the company’s innovative approach to women's healthcare. With a strong focus on developing and commercializing advanced incision-free, uterine-preserving technologies for the treatment of symptomatic uterine fibroids, Richard is at the forefront of transforming patient care in this critical area. His expertise in medical devices is complemented by a robust background in clinical research, allowing him to effectively validate the efficacy and safety of Gynesonics' groundbreaking solutions.
In his current role, Richard leads key projects that align clinical evidence with reimbursement strategies, ensuring that Gynesonics’ offerings not only meet regulatory standards but also achieve commercial viability. His strategic planning and product launch skills are instrumental in navigating the complexities of the medical device landscape, particularly in a startup environment where agility and innovation are paramount. Richard’s leadership is characterized by his ability to drive organizations through turnaround and change initiatives, leveraging his extensive experience in operations management and sales processes to foster a culture of excellence and accountability.
Richard's multifaceted skill set encompasses product marketing, business development, and FDA compliance, positioning him as a vital asset to Gynesonics. His commitment to improving women's healthcare through advanced medical technologies underscores his passion for making a meaningful impact in the industry. As he continues to spearhead initiatives that enhance patient outcomes, Richard remains dedicated to advancing the mission of Gynesonics and contributing to the broader healthcare community.
